Yuki Anraku
8PUBLICATIONS
69CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 15, 2025
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.Tomomi Kawakita, Toshiki Sekiya, Yayoi Kameda
|Mar 23, 2025
Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.Yuki Anraku, Shunsuke Kita, Taishi Onodera
|Oct 07, 2024
Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1.Hisano Yajima, Yuki Anraku, Yu Kaku
|Jul 04, 2024
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant.Shuhei Tsujino, Sayaka Deguchi, Tomo Nomai
|Feb 08, 2024
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.Tomokazu Tamura, Takashi Irie, Sayaka Deguchi
|Jul 14, 2023
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.Saya Moriyama, Yuki Anraku, Shunta Taminishi
Pageof 2
Frequent Collaborators
7 joint publications
Shunsuke Kita
6 joint publications
Takao Hashiguchi
6 joint publications
Katsumi Maenaka
4 joint publications
Kei Sato
3 joint publications
Yoshimasa Takahashi
3 joint publications
Terumasa Ikeda
3 joint publications
Kumiko Yoshimatsu
3 joint publications
Tomokazu Tamura
3 joint publications
Takasuke Fukuhara
3 joint publications
Arnon Plianchaisuk
